Chengdu, China, May 15, 2024 — JIADE LIMITED (the “Company” or “JDZG”), a company that focuses on providing comprehensive education…

The Federal Government of Germany and the Free State of Bavaria have commissioned the state development bank KfW in Frankfurt…

PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD) today announced that it will report its unaudited financial results…

New York, May 15, 2024 — As the cryptocurrency market continues to evolve and expand, investors are eagerly seeking insights…

Singapore, May 15, 2024 — Webuy Global Ltd (NASDAQ: WBUY) (“Webuy” or the “Company”), a Southeast Asian community e-commerce retailer,…

HONG KONG, May 15, 2024 — UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading…

HONG KONG, May 15, 2024 — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage…

COPX DAO is revolutionizing the financial sector by leveraging the power of AI to aggregate and analyze trading data from…

Andes, HiRain, and HPMicro have jointly announced that the three parties will cooperate to combine the AndesCoreTM RISC-V processor series,…

Vivoryon Therapeutics N.V. will report its financial results for the first quarter of 2024 and provide a corporate update on…

BEIJING, May 14, 2024 — Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”), a leading spatial-temporal intelligent big data…

BEIJING, May 14, 2024 — ATA Creativity Global (“ACG” or the “Company”, Nasdaq: AACG), an international educational services company focused…

XI’AN, China, May 14, 2024 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading…

Revenue totaled $31.8 million, representing a 59% increase year-over-year. Gross profit was $3.7 million, representing a 42% increase year-over-year. SINGAPORE,…

SEOUL, SOUTH KOREA, May 14, 2024 — Vine Strategy, a leading investment management firm focusing on clean energy and sustainable…

The company’s cash runway has been extended into July 2025 from previously April 2025. The capital raise has strengthened Medigene’s…

The company provided an updated clinical data on ACTengine® IMA203 targeting PRAME from the ongoing Phase 1 trial at the…